CVS Health Corporation (LON:0HRS)
London
· Delayed Price · Currency is GBP · Price in USD 69.02
+2.27 (3.41%)
At close: Aug 15, 2025
CVS Health Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 14, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 64,126 | 45,122 | 79,775 | 101,626 | 100,641 | 65,479 | Upgrade
|
| Market Cap Growth | 8.57% | -43.44% | -21.50% | 0.98% | 53.70% | -10.27% | Upgrade
|
| Enterprise Value | 114,776 | 103,581 | 130,083 | 144,295 | 149,477 | 120,772 | Upgrade
|
| Last Close Price | 50.87 | 34.24 | 57.44 | 69.39 | 67.14 | 42.35 | Upgrade
|
| PE Ratio | 19.39 | 12.24 | 12.18 | 28.40 | 17.03 | 12.45 | Upgrade
|
| PS Ratio | 0.23 | 0.15 | 0.28 | 0.38 | 0.47 | 0.33 | Upgrade
|
| PB Ratio | 1.13 | 0.75 | 1.33 | 1.71 | 1.81 | 1.28 | Upgrade
|
| P/FCF Ratio | - | 8.93 | 9.78 | 9.10 | 8.65 | 6.66 | Upgrade
|
| P/OCF Ratio | - | 6.20 | 7.57 | 7.57 | 7.46 | 5.64 | Upgrade
|
| EV/Sales Ratio | 0.41 | 0.35 | 0.47 | 0.54 | 0.70 | 0.62 | Upgrade
|
| EV/EBITDA Ratio | 9.19 | 10.28 | 8.99 | 8.71 | 10.86 | 9.11 | Upgrade
|
| EV/EBIT Ratio | 16.67 | 16.17 | 11.77 | 11.04 | 14.30 | 12.07 | Upgrade
|
| EV/FCF Ratio | 32.90 | 20.50 | 15.94 | 12.93 | 12.86 | 12.28 | Upgrade
|
| Debt / Equity Ratio | 1.07 | 1.10 | 1.04 | 0.99 | 1.01 | 1.22 | Upgrade
|
| Debt / EBITDA Ratio | 4.88 | 5.30 | 3.68 | 3.06 | 3.48 | 3.99 | Upgrade
|
| Debt / FCF Ratio | 17.31 | 13.11 | 7.64 | 5.26 | 4.83 | 6.33 | Upgrade
|
| Asset Turnover | 1.51 | 1.47 | 1.49 | 1.40 | 1.25 | 1.18 | Upgrade
|
| Inventory Turnover | 19.88 | 17.79 | 16.35 | 14.54 | 13.24 | 12.20 | Upgrade
|
| Quick Ratio | 0.58 | 0.56 | 0.59 | 0.62 | 0.55 | 0.53 | Upgrade
|
| Current Ratio | 0.80 | 0.81 | 0.86 | 0.95 | 0.89 | 0.91 | Upgrade
|
| Return on Equity (ROE) | 5.88% | 6.02% | 11.28% | 5.88% | 11.01% | 10.76% | Upgrade
|
| Return on Assets (ROA) | 2.29% | 1.99% | 3.68% | 4.27% | 3.82% | 3.77% | Upgrade
|
| Return on Capital (ROIC) | 3.66% | 3.19% | 5.89% | 6.70% | 5.78% | 5.55% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.70% | 4.80% | 8.30% | 9.90% | 8.60% | 8.10% | Upgrade
|
| Earnings Yield | 5.16% | 8.17% | 8.21% | 3.52% | 5.87% | 8.03% | Upgrade
|
| FCF Yield | 5.44% | 11.20% | 10.23% | 10.98% | 11.55% | 15.02% | Upgrade
|
| Dividend Yield | 3.10% | 6.21% | 3.31% | 2.63% | 2.20% | 3.46% | Upgrade
|
| Payout Ratio | 74.62% | 73.10% | 37.54% | 67.43% | 32.81% | 36.55% | Upgrade
|
| Buyback Yield / Dilution | 1.02% | 2.17% | 2.49% | 0.45% | -1.14% | -0.69% | Upgrade
|
| Total Shareholder Return | 4.12% | 8.38% | 5.80% | 3.08% | 1.06% | 2.77% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.